BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3979470)

  • 21. Differentiation of mixed colony-forming cells in normal human bone marrow and blood.
    Dresch C; Barreau P
    Exp Hematol; 1985 Dec; 13(11):1143-51. PubMed ID: 4065263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2'5'-adenylate inhibition of erythropoietin-dependent colony formation.
    Orlic D; Quaini F; Konski AA; Wu JM
    Stem Cells (1981); 1982; 1(4-5):261-8. PubMed ID: 7147092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
    Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
    Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hematopoietic stem cells in the hereditarily anemic Belgrade laboratory (b/b) rat.
    Ivanović Z; Milenković P; Vasiljevska M; Dekić M
    Exp Hematol; 1995 Oct; 23(11):1218-23. PubMed ID: 7556533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevation of erythroid colony-stimulating activity in the serum of mice with graft-versus-host disease.
    Kanamaru A; Okamoto T; Matsuda K; Hara H; Nagai K
    Exp Hematol; 1984 Nov; 12(10):763-7. PubMed ID: 6334610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
    Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
    Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Megakaryocytopoiesis in vitro: from the stem cells' perspective.
    Cardier JE; Foster DC; Lok S; Jacobsen SE; Murphy MJ
    Stem Cells; 1996; 14 Suppl 1():163-72. PubMed ID: 11012217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved assessment of bioactive erythropoietin in human sera using a modified tritiated-thymidine-incorporation assay.
    Paul P; Rothmann SA; Zydiak L; Beck GJ
    Exp Hematol; 1987 May; 15(4):382-8. PubMed ID: 3569440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of the growth of human early erythroid progenitors by bone marrow conditioned media.
    Porter PN; Ogawa M; Leary AG
    Exp Hematol; 1980 Jan; 8(1):83-8. PubMed ID: 7409039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of murine erythroid progenitors with high erythropoietin sensitivity in vitro.
    Monette FC; Ouellette PL; Faletra PP
    Exp Hematol; 1981 Mar; 9(3):249-56. PubMed ID: 7227476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythroid colony formation in cultures of mouse and human bone marrow: analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose-concanavalin A.
    Iscove NN; Sieber F; Winterhalter KH
    J Cell Physiol; 1974 Apr; 83(2):309-20. PubMed ID: 4822532
    [No Abstract]   [Full Text] [Related]  

  • 33. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow failure following severe injury in humans.
    Livingston DH; Anjaria D; Wu J; Hauser CJ; Chang V; Deitch EA; Rameshwar P
    Ann Surg; 2003 Nov; 238(5):748-53. PubMed ID: 14578739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of retroviral-mediated gene transduction of both the recombinant human erythropoietin receptor and interleukin-9 receptor genes into single CD34++CD33-or low cord blood cells on cytokine-stimulated erythroid colony formation.
    Lu L; Ge Y; Li ZH; Xiao M; Broxmeyer HE
    Exp Hematol; 1996 Feb; 24(2):347-51. PubMed ID: 8641364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cryopreservation of the human multipotent stem cell.
    Fabian I; Douer D; Wells JR; Cline MJ
    Exp Hematol; 1982 Jan; 10(1):119-22. PubMed ID: 7060656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regeneration of erythroid committed precursor cells in polycythaemic mice treated with cyclophosphamide.
    Milenković P; Pavlović-Kentera V
    Exp Hematol; 1980 Jan; 8(1):44-51. PubMed ID: 7409037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Murine erythroid colony-promoting factor derived from thymocyte conditioned media.
    Maeda H; Hotta T; Yamada H
    Exp Hematol; 1983 Oct; 11(9):834-40. PubMed ID: 6605867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of flt3 ligand on in vitro growth and expansion of colony-forming bone marrow cells from patients with aplastic anemia.
    Wodnar-Filipowicz A; Chklovskaia E; Manz CY; Lyman SD; Nissen C
    Exp Hematol; 1997 Jul; 25(7):573-81. PubMed ID: 9216732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum-free culture conditions for cells capable of producing long-term survival in lethally irradiated mice.
    Brown RL; Xu FS; Dusing SK; Li Q; Fischer R; Patchen M
    Stem Cells; 1997; 15(3):237-45. PubMed ID: 9170216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.